UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CYP2D activity in the brain acts independently from CYP2D in the liver to alter CNS drug levels and response

European neuropsychopharmacology, 2016-10, Vol.26, p.S119-S119

2016

Volltextzugriff (PDF)

Ethanol self‐administration and nicotine treatment increase brain levels of CYP2D in African green monkeys

British journal of pharmacology, 2014-06, Vol.171 (12), p.3077-3088

2014

Volltextzugriff (PDF)

Differential effects of nicotine treatment and ethanol self-administration on CYP2A6, CYP2B6 and nicotine pharmacokinetics in African green monkeys

The Journal of pharmacology and experimental therapeutics, 2012-12, Vol.343 (3), p.628-637

2012

Volltextzugriff (PDF)

Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment

Molecular psychiatry, 2017-08, Vol.22 (8), p.1155-1163

2017

Volltextzugriff (PDF)

Haloperidol-induced catalepsy, a model of acute antipsychotic-induced extrapyramidal side effects, is altered by inhibiting and inducing CYP2D in rat brain

European neuropsychopharmacology, 2016-10, Vol.26, p.S237-S238

2016

Volltextzugriff (PDF)

Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain

Neuropharmacology, 2003-07, Vol.45 (1), p.122-132

2003

Volltextzugriff (PDF)

The Unique Regulation of Brain Cytochrome P450 2 (CYP2) Family Enzymes by Drugs and Genetics

Drug metabolism reviews, 2004, Vol.36 (2), p.313-333

2004

Volltextzugriff (PDF)

Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment

Molecular psychiatry, 2017-08, Vol.22 (8), p.1224-1224

2017

Volltextzugriff (PDF)

Neurodegenerative Diseases: A Growing Challenge

Clinical pharmacology and therapeutics, 2010-10, Vol.88 (4), p.427-430

2010

Volltextzugriff (PDF)

Twenty-First-Century Neuroscience: The Potential for Innovative Therapies for Brain Disorders

Clinical pharmacology and therapeutics, 2012-02, Vol.91 (2), p.153-157

2012

Volltextzugriff (PDF)

Independent and combined effects of ethanol self-administration and nicotine treatment on hepatic CYP2E1 in African green monkeys

Drug metabolism and disposition, 2011-12, Vol.39 (12), p.2233-2241

2011

Volltextzugriff (PDF)

Brain and Disease: The Long Path to Discovery and Treatment

Clinical pharmacology and therapeutics, 2009-10, Vol.86 (4), p.343-346

2009

Volltextzugriff (PDF)

CYP2C19 expression is associated with depressive symptoms and hippocampal serotonin homeostasis impairment

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, Vol.26, p.S379-S380

2016

Volltextzugriff (PDF)

Nicotine induces brain CYP enzymes: relevance to Parkinson’s disease

Journal of neural transmission. Supplementum, 2006 (70), p.177-180

2006

Volltextzugriff (PDF)

S.05.03 - CYP2D activity in the brain acts independently from CYP2D in the liver to alter CNS drug levels and response

European neuropsychopharmacology, 2016-10, Vol.26, p.S119-S119

2016

Volltextzugriff (PDF)

Cytochrome P450―mediated drug metabolism in the brain

Journal of psychiatry & neuroscience, 2013-05, Vol.38 (3), p.152-163

2013

Volltextzugriff (PDF)

Drug-metabolizing cytochrome P450s in the brain

Journal of psychiatry & neuroscience, 2002-11, Vol.27 (6), p.406-415

2002

Volltextzugriff (PDF)

Rat brain CYP2D activity alters in vivo central oxycodone metabolism, levels and resulting analgesia

Addiction biology, 2019-03, Vol.24 (2), p.228-238

2019

Volltextzugriff (PDF)

The distribution of a CRF-like diuretic peptide in the blood-feeding bug Rhodnius prolixus

Journal of experimental biology, 1999-08, Vol.202 (Pt 15), p.2017-2027

1999

Volltextzugriff (PDF)

Regional and cellular distribution of CYP2D subfamily members in rat brain

Xenobiotica, 2000-06, Vol.30 (6), p.547-564

2000

Volltextzugriff (PDF)

P.358 Reduced cerebellum volume and ataxia-like motoric phenotype in transgenic mouse, carrier of human CYP2C19 gene

European neuropsychopharmacology, 2020-11, Vol.40, p.S207-S208

2020

Volltextzugriff (PDF)

S.24.07 Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia

European neuropsychopharmacology, 2019-12, Vol.29, p.S17-S17

2019

Volltextzugriff (PDF)

P.571 Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia

European neuropsychopharmacology, 2019-12, Vol.29, p.S399-S400

2019

Volltextzugriff (PDF)

Ethanol self‐administration and nicotine treatment increase brain levels of CYP 2 D in A frican green monkeys

British journal of pharmacology, 2014-06, Vol.171 (12), p.3077-3088

2014

Volltextzugriff (PDF)

P.2.25 Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia

European neuropsychopharmacology, 2019, Vol.29, p.S672-S673

2019

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(77)
Life Sciences & Biomedicine
(70)
Animals
(43)
Male
(36)
Humans
(31)
Pharmacology & Pharmacy
(31)
Biological And Medical Sciences
(24)
Neurosciences
(23)
Neurosciences & Neurology
(23)
Brain - Enzymology
(18)
Rats
(18)
Brain
(17)
Brain - Drug Effects
(16)
Nicotine
(16)
Fundamental And Applied Biological Sciences. Psychology
(14)
Immunohistochemistry
(14)
Psychiatry
(14)
Rats, Wistar
(14)
Nicotine - Pharmacology
(13)
Brain - Metabolism
(12)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

CYP2D activity in the brain acts independently from CYP2D in the liver to alter CNS drug levels and response

Ethanol self‐administration and nicotine treatment increase brain levels of CYP2D in African green monkeys

Differential effects of nicotine treatment and ethanol self-administration on CYP2A6, CYP2B6 and nicotine pharmacokinetics in African green monkeys

Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment

Haloperidol-induced catalepsy, a model of acute antipsychotic-induced extrapyramidal side effects, is altered by inhibiting and inducing CYP2D in rat brain

Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain

The Unique Regulation of Brain Cytochrome P450 2 (CYP2) Family Enzymes by Drugs and Genetics

Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment

Neurodegenerative Diseases: A Growing Challenge

Twenty-First-Century Neuroscience: The Potential for Innovative Therapies for Brain Disorders

Independent and combined effects of ethanol self-administration and nicotine treatment on hepatic CYP2E1 in African green monkeys

Brain and Disease: The Long Path to Discovery and Treatment

CYP2C19 expression is associated with depressive symptoms and hippocampal serotonin homeostasis impairment

Nicotine induces brain CYP enzymes: relevance to Parkinson’s disease

S.05.03 - CYP2D activity in the brain acts independently from CYP2D in the liver to alter CNS drug levels and response

Cytochrome P450―mediated drug metabolism in the brain

Drug-metabolizing cytochrome P450s in the brain

Rat brain CYP2D activity alters in vivo central oxycodone metabolism, levels and resulting analgesia

The distribution of a CRF-like diuretic peptide in the blood-feeding bug Rhodnius prolixus

Regional and cellular distribution of CYP2D subfamily members in rat brain

P.358 Reduced cerebellum volume and ataxia-like motoric phenotype in transgenic mouse, carrier of human CYP2C19 gene

S.24.07 Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia

P.571 Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia

Ethanol self‐administration and nicotine treatment increase brain levels of CYP 2 D in A frican green monkeys

P.2.25 Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia

Suchergebnisse filtern